1. Home
  2. IBIO vs ALIS Comparison

IBIO vs ALIS Comparison

Compare IBIO & ALIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo iBio Inc.

IBIO

iBio Inc.

HOLD

Current Price

$1.71

Market Cap

72.2M

Sector

Health Care

ML Signal

HOLD

ALIS

Calisa Acquisition Corp Ordinary shares

N/A

Current Price

$9.98

Market Cap

83.9M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
IBIO
ALIS
Founded
2008
2024
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
72.2M
83.9M
IPO Year
2009
N/A

Fundamental Metrics

Financial Performance
Metric
IBIO
ALIS
Price
$1.71
$9.98
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$4.75
N/A
AVG Volume (30 Days)
1.1M
7.3K
Earning Date
05-01-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
73.08
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.56
$9.87
52 Week High
$4.19
$10.07

Technical Indicators

Market Signals
Indicator
IBIO
ALIS
Relative Strength Index (RSI) 31.86 46.95
Support Level $1.70 $9.96
Resistance Level $1.81 $10.03
Average True Range (ATR) 0.21 0.01
MACD -0.08 -0.00
Stochastic Oscillator 20.91 28.57

Price Performance

Historical Comparison
IBIO
ALIS

About IBIO iBio Inc.

iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.

About ALIS Calisa Acquisition Corp Ordinary shares

Calisa Acquisition Corp is a blank check company with the purpose of effecting a merger, asset acquisition, stock exchange, stock purchase, reorganization, or similar business combination.

Share on Social Networks: